Pasithea Therapeutics Corp. (KTTAW) Current Leases (2022 - 2024)

Pasithea Therapeutics has disclosed Current Leases across 3 years of filings, most recently posting $32989.0 for Q1 2024.

• In Q1 2024, Current Leases fell 80.0% year-over-year to $32989.0; the TTM figure through Mar 2024 stood at $32989.0 (down 80.0% YoY), while the FY2023 annual figure was $81680.0, down 49.07% from the prior year.
• Current Leases came in at $32989.0 for Q1 2024 at Pasithea Therapeutics, down from $81680.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $258031.0 in Q3 2022 to a low of $32989.0 in Q1 2024.
• Average Current Leases over 3 years is $142950.1, with a median of $162668.0 recorded in 2022.
• Year-over-year, Current Leases jumped 67.3% in 2023 and slumped 80.0% in 2024.
• Over 3 years, Current Leases stood at $160362.0 in 2022, then tumbled by 49.07% to $81680.0 in 2023, then slumped by 59.61% to $32989.0 in 2024.
• Per Business Quant data, the three most recent Current Leases figures were $32989.0 in Q1 2024, $81680.0 in Q4 2023, and $174471.0 in Q3 2023.